| P2093 | author name string | Karl A Matuszewski | |
| | Nicole R Wulf | |
| P2860 | cites work | Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs | Q44393546 |
| | Selective celecoxib-associated anaphylactoid reaction | Q44467296 |
| | Anaphylactic drug reaction to celecoxib and sulfamethoxazole: cross reactivity or coincidence? | Q44596940 |
| | Anaphylaxis to oral furosemide | Q44689525 |
| | Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity | Q44790837 |
| | Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing | Q45063448 |
| | Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test | Q45257750 |
| | Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole | Q45309388 |
| | Severe allergic reaction to hydrochlorothiazide mimicking septic shock | Q46101313 |
| | A successful rapid desensitization protocol in a loop diuretic allergic patient | Q46654742 |
| | Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient | Q46849954 |
| | Concomitant sensitization to enoxolone and mafenide in a topical medicament | Q46869882 |
| | Difference in Risks of Allergic Reaction to Sulfonamide Drugs Based on Chemical Structure | Q63865851 |
| | Anaphylaxis to intravenous furosemide | Q69425466 |
| | Allergic contact dermatitis from topical mafenide | Q70753807 |
| | Allergic skin reaction to celecoxib | Q73366977 |
| | Celecoxib-induced acute pancreatitis and hepatitis: a case report | Q73495274 |
| | Celecoxib allergies and cross-reactivity | Q79238671 |
| | Sulfonamide allergy without cross-reactivity to celecoxib | Q79420280 |
| | Sulfamethoxazole is metabolized to the hydroxylamine in humans | Q28319853 |
| | Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine | Q28333984 |
| | Studies of human IgE to a sulfonamide determinant | Q28337746 |
| | Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo | Q28364889 |
| | T-cell involvement in drug-induced acute generalized exanthematous pustulosis | Q28366339 |
| | Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy | Q33944895 |
| | Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis | Q34057610 |
| | Idiosyncratic drug reactions: the reactive metabolite syndromes | Q34081284 |
| | Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics | Q34271822 |
| | Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group | Q34339975 |
| | Sulfonamide cross-reactivity: fact or fiction? | Q34383669 |
| | Presumed "sulfa allergy" in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality? | Q34549094 |
| | Allergic adverse reactions to sulfonamides. | Q34564723 |
| | Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus | Q34612144 |
| | Ethacrynic acid and the sulfa-sensitive patient | Q35043657 |
| | Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients | Q36428422 |
| | Hydrochlorothiazide-induced angioedema in a patient allergic to sulfonamide antibiotics: evidence from a case report and a review of the literature | Q36734330 |
| | Sulfonamide allergy and cross-reactivity | Q36823136 |
| | Predicting possible zonisamide hypersensitivity syndrome | Q38476341 |
| | Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. | Q40493792 |
| | Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole | Q42211398 |
| | Anaphylactic shock after a single oral intake of acetazolamide | Q43094751 |
| | Rapid oral desensitization to furosemide | Q43190258 |
| | Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity | Q43190608 |
| | Immunologic tolerability profile of celecoxib | Q43454000 |
| | Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals | Q43503900 |
| | Celecoxib-induced cholestatic hepatitis | Q43525762 |
| | Amprenavir-induced maculopapular exanthem followed by desensitization in a patient with late-stage human immunodeficiency virus | Q43616193 |
| | Allergic contact blepharoconjunctivitis from dorzolamide | Q43782446 |
| | Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides | Q43830453 |
| | Use of optical biosensor technology to study immunological cross-reactivity between different sulfonamide drugs | Q43846440 |
| | Celecoxib-induced erythema multiforme with glyburide cross-reactivity | Q43995323 |
| | Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide. | Q44050447 |
| | Safety of celecoxib in individuals allergic to sulfonamide: a pilot study | Q44311321 |
| | Furosemide challenge in patients with heart failure and adverse reactions to sulfa-containing diuretics | Q44314377 |
| P433 | issue | 17 | |
| P921 | main subject | allergenicity | Q112335957 |
| P304 | page(s) | 1483-1494 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | American Journal of Health-System Pharmacy | Q15754037 |
| P1476 | title | Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? | |
| P478 | volume | 70 | |